Ortho Molecular Strontium Musculoskeletal Health Strontium is a mineral that has similar physical and chemical properties to calcium. Research has shown that strontium provides all-natural bone support. Bone is the rigid structure that makes up our skeleton, but it is actually an active, living organ that is constantly being built up and broken down by osteoblasts and osteoclasts. The proper balance of this cycle and turnover of bone provides the foundation for strong bones over a lifetime. Strontium is a mineral that has similar physical and chemical properties to calcium. Research has shown strontium provides all-natural bone support through its ability to naturally increase the formation of osteoblasts (cells that build up bone) and slow down the formation of osteoclasts (cells that break down bone tissue), helping to maintain healthy bone density. Key Benefits and Features: Provides Musculoskeletal Support Provides All-Natural Bone Support Increases Skeletal Strength and Helps Maintain Bone Density Ingredients Serving Size: 1 Capsule Amount/Serving Strontium (from 950 mg of Strontium Sitrate) 300 mg Other Ingredients: None. Does Not Contain: Gluten, corn, yeast, artificial colors, or flavors. Suggested Use Take 1 capsule two times per day or as recommended by your health care professional. For maximum absorption, do not consume with calcium supplements. Warning: If you are pregnant or nursing, consult your physician before taking this product. Keep out of the reach of children. Storage: Keep tightly closed in a cool, dry place. More Info. Bone and Skeletal Health A growing body of research highlights the benefits of strontium in skeletal health. A head-to-head study comparing SrC to strontium ranelate (SrR) in rats found both forms deliver equivalent amounts of elemental strontium. In the study, equivalent doses of both forms of strontium or placebo were given, and assimilation into bone was compared for 19 weeks and followed for another eight weeks. The study confirmed the equivalent delivery of SrC into bone compared to SrR and the potential of SrC to support bone structure. Recent case studies demonstrate SrC adequately supports BMD in older women. The Journal of Nutritional Health & Food Science reported three cases of older women who took SrC on their own and saw bone density supported. In these cases, the subjects chose to discontinue traditional therapies. Another unique case was published of a woman who decided to take SrC and allow researchers at McMaster University to follow her bone strontium levels for nearly three years. The subject was 68 years old and had no history of supplementing strontium in any form prior to the study. The patient supplemented with two doses of SrC, which provided 680 mg of strontium per day. Researchers measured the changes in strontium levels in her finger and ankle bones. Not only did her bone strontium levels statistically increase after just five days, but they continued to increase until they reached a plateau after one year. A 2014 clinical trial published in Bone recruited 10 female volunteers who also self-supplemented with 680 mg of strontium per day and found similar results upon evaluation. Two recent clinical studies also demonstrate that SrC supports BMD and bone quality biomarkers. The COMB Study offered female patients in need of bone support a micronutrient protocol; these patients had refused or failed to respond to past treatments. After 12 months of consecutive supplemental micronutrient therapy with a combination that included vitamin D3, vitamin K2, SrC, magnesium, and docosahexaenoic acid (DHA), repeat bone densitometry was performed. The results showed that bone was supported in the hip, spine, and femoral neck sites. Benefits were found in the group taking the micronutrient protocol.6 The MOTS Study was a one-year, double-blind, placebo-controlled trial that assessed the effects of nightly melatonin, SrC, vitamin D3, and vitamin K2 (MK-7) (MSDK) on BMD and quality of life in women ages 4975. Compared to placebo, MSDK supported BMD in the lumbar spine and femoral neck and supported bone biomarkers. This demonstrates improved bone quality and collagen preservation. Quality of life scores, osteoblast activity, and osteoclast activity were also found to be supported. Strontium Safety Past risk analysis studies of SrR have suggested precaution. A recent 2014 review in Expert Opinion on Drug Safety concluded good tolerability and safety profiles in long-term studies. Further, the safety and side effects reported in the PREVOS, STRATOS, TROPOS and SOTI trials do not indicate any adverse events with long-term strontium use.
